Defective myogenic response to posture change in retinal vessels of well-controlled type 1 diabetic patients with no retinopathy

Investigative Ophthalmology and Visual Science

Volumn 51, Issue 12, 2010, Pages 6770-6775

  Lorenzi, Mara ^a,b   Feke, Gilbert T ^a,c,d   Pitler, Linda ^a   Berisha, Fatmire ^c,d   Kolodjaschna, Julia ^c,d   Wallace Mcmeel, J ^a,b,d  

^a SCHEPENS EYE RESEARCH INSTITUTE   (United States)

^b Ophthalmology   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d Retina Associates Boston   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN;

ADULT; ARTERY DIAMETER; ARTICLE; BODY POSTURE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC RETINOPATHY; EYE EXAMINATION; EYE FUNDUS; EYE PHOTOGRAPHY; FEMALE; HEMODYNAMIC PARAMETERS; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MALE; PERFUSION PRESSURE; PRIORITY JOURNAL; RETINA BLOOD VESSEL; RETINA FOVEA;

ADOLESCENT; ADULT; ARTERIOLES; BIOLOGICAL MARKERS; BLOOD FLOW VELOCITY; BLOOD PRESSURE; DIABETES MELLITUS, TYPE 1; FEMALE; HEART RATE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INFANT, NEWBORN; LASER-DOPPLER FLOWMETRY; MALE; MIDDLE AGED; MUSCLE, SMOOTH, VASCULAR; POSTURE; REGIONAL BLOOD FLOW; RETINAL ARTERY; RETINOPATHY OF PREMATURITY; TOMOGRAPHY, OPTICAL COHERENCE; VASOCONSTRICTION; YOUNG ADULT;

EID: 79955977001     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.10-5785     Document Type: Article

References (44)

1. Orchard TJ, Dorman JS, Maser RE, et al. Prevalence of complications in IDDM by sex and duration: Pittsburgh Epidemiology of Diabetes Complications Study II. Diabetes. 1990;39:1116-1124.
2. Krolewski AS, Warram JH, Rand LI, Kahn CR. Epidemiologic approach to the etiology of type I diabetes mellitus and its complications. N Engl J Med. 1987;317:1390-1397.
3. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977-986.
4. Mohsin F, Craig ME, Cusumano J, et al. Discordant trends in microvascular complications in adolescents with type 1 diabetes from 1990 to 2002. Diabetes Care. 2005;28:1974-1980.
5. Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Research Group. Modern day clinical course of type 1 diabetes mellitus after 30 years' duration: the Diabetes Control and Complications Trial/ Epidemiology of Diabetes Interventions and Complications and Pittsburgh Epidemiology of Diabetes Complications experience. Arch Intern Med. 2009;169:1307-1313.
6. Lorenzi M. Mechanisms and strategies for prevention of diabetic retinopathy. Curr Diabetes Rep. 2006;6:102-107.
7. Cheung N, Rogers SL, Donaghue KC, Jenkins AJ, Tikellis G, Wong TY. Retinal arteriolar dilation predicts retinopathy in adolescents with type 1 diabetes. Diabetes Care. 2008;31:1842-1846.
8. Lorenzi M, Feke GT, Cagliero E, et al. Retinal haemodynamics in individuals with well-controlled type 1 diabetes. Diabetologia. 2008;51:361-364.
9. Pournaras Cj, Rungger-Brandle E, Riva CE, Hardarsonn SH, Stefansson E. Regulation of retinal blood flow in health and disease. Prog Retin Eye Res. 2008;27:284-330.
10. Bursell SE, Clermont AC, Kinsley BT, Simonson DC, Aiello LM, Wolpert HA. Retinal blood flow changes in patients with insulindependent diabetes mellitus and no diabetic retinopathy. Invest Ophthalmol Vis Sci. 1996;37:886-897.
11. Garhöfer G, Zawinka C, Resch H, Kothy P, Schmetterer L, Dorner GT. Reduced response of retinal vessel diameters to flicker stimulation in patients with diabetes. Br J Ophthalmol. 2004;88:887-891.
12. Holopigian K, Seiple W, Lorenzo M, Carr R. A comparison of photopic and scotopic electroretinographic changes in early diabetic retinopathy. Invest Ophthalmol Vis Sci. 1992;33:2773-2780.
13. Grunwald JE, Riva CE, Brucker AJ, Sinclair SH, Petrig BL. Altered retinal vascular response to 100% oxygen breathing in diabetes mellitus. Ophthalmology. 1984;91:1447-1452.
14. Trick GL, Edwards P, Desai U, Berkowitz BA. Early supernormal retinal oxygenation response in patients with diabetes. Invest Ophthalmol Vis Sci. 2006;47:1612-1619.
15. Kohner EM, Patel V, Rassam SM. Role of blood flow and impaired autoregulation in the pathogenesis of diabetic retinopathy. Diabetes. 1995;44:603-607.
16. Feke GT, Pasquale LR. Retinal blood flow response to posture change in glaucoma patients compared with healthy subjects. Ophthalmology. 2008;115:246-252.
17. Dumskyj MJ, Eriksen JE, Dore' CJ, Kohner EM. Autoregulation in the human retinal circulation: assessment using isometric exercise, laser Doppler velocimetry, and computer-assisted image analysis. Microvasc Res. 1996;51:378-392.
18. Delaey C, Van de Voorde J. Pressure-induced myogenic responses in isolated bovine retinal arteries. Invest Ophthalmol Vis Sci. 2000;41:1871-1875.
19. Bressler NM, Edwards AR, Antoszyk AN, et al. Retinal thickness on Stratus optical coherence tomography in people with diabetes and minimal or no diabetic retinopathy. Am J Ophthalmol. 2008;145:894-901.
20. Frank RN, Schulz L, Abe K, Iezzi R. Temporal variation in diabetic macular edema measured by optical coherence tomography. Ophthalmology. 2004;111:211-217.
21. Chan A, Duker JS, Ko TH, Fujimoto JG, Schuman JS. Normal macular thickness measurements in healthy eyes using Stratus optical coherence tomography. Arch Ophthalmol. 2006;124:193-198.
22. Yoshida A, Feke GT, Mori F, et al. Reproducibility and clinical application of a newly developed stabilized retinal laser Doppler instrument. Am J Ophthalmol. 2003;135:356-361.
23. Tang J, Mohr S, Du J-P, Kern TS. Non-uniform distribution of lesions and biochemical abnormalities within the retina of diabetic humans. Curr Eye Res. 2003;27:7-13.
24. Hague S, Hill DW. Postural changes in perfusion pressure and retinal arteriolar caliber. Br J Ophthalmol. 1988;72:253-257.
25. Caprioli J, Coleman AL. Blood pressure, perfusion pressure, and glaucoma. Am J Ophthalmol. 2010;149:704-712.
26. Selvadurai D, Hodge D, Sit AJ. Aqueous humor outflow facility by tonography does not change with body position. Invest Ophthalmol Vis Sci. 2010;51:1453-1457.
27. Wise GN, Dollery CT, Henkind P. Physiologic principles. The Retinal Circulation. 1st ed. New York: Harper & Row; 1971:94-95.
28. Grunwald JE, DuPont J, Riva CE. Retinal haemodynamics in patients with early diabetes mellitus. Br J Ophthalmol. 1996;80:327-331.
29. Bevan JA, Laher I. Pressure and flow-dependent vascular tone. FASEB J. 1991;5:2267-2273.
30. Scholfield CN, McGeown JG, Curtis TM. Cellular physiology of retinal and choroidal arteriolar smooth muscle cells. Microcirculation. 2007; 14:11-24.
31. Schofield I, Malik R, Izzard A, Austin C, Heagerty A. Vascular structural and functional changes in type 2 diabetes mellitus: evidence for the roles of abnormal myogenic responsiveness and dyslipidemia. Circulation. 2002;106:3037-3043.
32. Mizutani M, Kern TS, Lorenzi M. Accelerated death of retinal microvascular cells in human and experimental diabetic retinopathy. J Clin Invest. 1996;97:2883-2890.
33. Gardiner TA, Archer DB, Curtis TM, Stitt AW. Arteriolar involvement in the microvascular lesions of diabetic retinopathy: implications for pathogenesis. Microcirculation. 2007;14:25-38.
34. Blum M, Kloos C, Günther S, Hunger-Dathe W, Müller UA. Improved metabolic control results in better myogenic response of retinal arterioles in patients with diabetes mellitus type 1. Ophthalmologica. 2008;222:373-377.
35. Brayden JE, Earley S, Nelson MT, Reading S. Transient receptor potential (TRP) channels, vascular tone and autoregulation of cerebral blood flow. Clin Exp Pharmacol Physiol. 2008;35:1116-1120.
36. Luksch A, Wimpissinger B, Polak K, Jandrasits K, Schmetterer L. ETa-receptor blockade, but not ACE inhibition, blunts retinal vessel response during isometric exercise. Am J Physiol Heart Circ Physiol. 2006;290:H1693-H1698.
37. Blum M, Brändel C, Müller UA. Myogenic response reduction by high blood glucose levels in human retinal arterioles. Eur J Ophthalmol. 2005;15:56-61.
38. Ito I, Jarajapu YP, Guberski DL, Grant MB, Knot HJ. Myogenic tone and reactivity of rat ophthalmic artery in acute exposure to high glucose and in a type II diabetic model. Invest Ophthalmol Vis Sci. 2006;47:683-692.
39. Cipolla MJ, Porter JM, Osol G. High glucose concentrations dilate cerebral arteries and diminish myogenic tone through an endothelial mechanism. Stroke. 1997;28:405-411.
40. T. Novel risk markers and clinical practice. N Engl J Med. 2003;349:1587-1589.
41. Morrow DA, de Lemos JA. Benchmarks for the assessment of novel cardiovascular biomarkers. Circulation. 2007;115:949-952.
42. Goldsmith HL. The microrheology of red blood cell suspensions. J Gen Physiol. 1968;52:5s-28s.
43. Berkowitz BA, Roberts R. Prognostic MRI biomarkers of treatment efficacy for retinopathy. NMR Biomed. 2008;21:957-967.
44. Knudsen ST, Bek T, Poulsen PL, Hove MN, Rehling M, Mogensen CE. Macular edema reflects generalized vascular hyperpermeability in type 2 diabetic patients with retinopathy. Diabetes Care. 2002; 25:2328-2334.